TBE Seropersistence up to 10 Years After First Booster in Adults

Clinical trial NCT01582698 · COMPLETED

Trial details

NCT number: NCT01582698
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Tick-borne Encephalitis (TBE)

Start date: 2012-04-01
Primary completion: 2015-06-01
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.